
A new study aims to show how genetic testing could help personalise treatments by boosting medication response and reducing harmful side effects.
The landmark trial will recruit up to 4,000 patients over the next two years in the NHS Greater Glasgow and Clyde area, to investigate how an individual’s genetic profile affects their response to 60 common medications.